DNDN

Dendreon Corporation News Headlines

$1.03
*  
0.01
0.96%
Get DNDN Alerts
*Delayed - data as of Oct. 24, 2014  -  Find a broker to begin trading DNDN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Cramer Lightning Round - People's United Financial Is Like Watching Paint Dry (2/8/12)
2/9/2012 7:09:00 AM - Seeking Alpha


A Closer Look At 5 Headline Stocks
2/9/2012 4:44:00 AM - Seeking Alpha


ImmunoCellular And Cancer Treatment's Next Frontier
2/8/2012 12:41:00 PM - Seeking Alpha


Trading Biotech In Pairs: A Better Way To Hedge
2/7/2012 10:06:00 AM - Seeking Alpha


Top Q4 Buys And Sells Of Healthcare-Focused Hambrecht And Quist Capital Management
2/7/2012 2:36:00 AM - Seeking Alpha


Dendreon Gains Will Be Short-Lived
2/6/2012 7:03:00 PM - Seeking Alpha


VIX - Options Volatility Sonar: Monday Recap
2/6/2012 3:57:00 PM - Seeking Alpha


Teva Invests In Immuno-Therapy For Deadly Cancer Research
2/6/2012 2:04:00 PM - Seeking Alpha


Dendreon Gets a New CEO - Analyst Blog
2/2/2012 7:33:01 PM - Zacks.com


Departure Of CEO From Savient Is Disturbing, But I Retain My Rating On The Stock
2/2/2012 3:50:00 PM - Seeking Alpha


Three Paths For Dendreon As Provenge Plods Toward Profits
2/1/2012 11:55:00 AM - Seeking Alpha


Dendreon And Provenge's True Median Life-Extension Benefit
2/1/2012 11:01:00 AM - Seeking Alpha


Dendreon's Provenge And JNJ's Zytiga Both Had Strong Early Sales
1/31/2012 4:35:00 AM - Seeking Alpha


Top Q4 Undervalued Buys And Sells Of Vanguard's $632 Billion In 13-F Assets
1/31/2012 3:27:00 AM - Seeking Alpha


Antares's New RA Treatment Method Has Large Market Potential
1/30/2012 5:52:00 PM - Seeking Alpha


Best Performing Stocks Year To Date
1/30/2012 3:49:00 PM - Seeking Alpha


Stocks To Watch Week Of Jan. 30
1/30/2012 2:13:00 PM - Seeking Alpha


5 Stocks To Watch For Big Moves This Week
1/30/2012 8:03:00 AM - Seeking Alpha


Arena Pharmaceuticals Has Over A 300% Upside Potential In 2012
1/29/2012 4:34:00 AM - Seeking Alpha


15 Healthcare Stocks Insiders Bought Recently
1/27/2012 12:55:00 PM - Seeking Alpha


12 Healthcare Stocks With Bearish Short Trends
1/27/2012 1:39:00 AM - Seeking Alpha


Cramer's Mad Money - The Worst May Be Over For Johnson & Johnson (1/25/12)
1/26/2012 6:32:00 AM - Seeking Alpha


2011 Review And Outlook For Biotechnology In 2012
1/25/2012 4:02:00 PM - Seeking Alpha


Philanthropy: A Huge Driver Of Speculative Bio-Pharma
1/25/2012 2:37:00 PM - Seeking Alpha


Immunotherapy Cancer Trials With Key Data Due In 2012
1/25/2012 11:40:00 AM - Seeking Alpha